Lake Street initiates coverage on Kazia Therapeutics (NASDAQ: KZIA) with a Buy rating and a price target of $32.00.

For an analyst ratings summary and ratings history on Kazia Therapeutics click here. For more ratings news on Kazia Therapeutics click here.

Shares of Kazia Therapeutics closed at $11.50 yesterday.